Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 15,214 | $30.00 | $456,420.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 32,524 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 31,870 | $30.00 | $956,100.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Foundation Disclosed balance after: 68,130 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 3,665 | $30.00 | $109,950.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 7,835 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 1,401,856 | $30.00 | $42,055,680.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,996,744 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 21:52 UTC |
Waldin Jan-PaulDirector
|
Disposition to issuerCommon Stock | 95,612 | $30.00 | $2,868,360.00 |
DisclosureSEC source: 0001209191-20-009282 · doc4.xml · nonDerivative · entry 1 Waldin Jan-Paul · CIK 0001733176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,388 Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 15:05 UTC |
GUT THOMAS10% owner
|
Disposition to issuerCommon Stock | 1,868,870 | $30.00 | $56,066,100.00 |
DisclosureSEC source: 0001104659-20-021546 · tm208173d1_form4.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,995,170 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. The number of shares reported is an estimate, and will be amended when a final determination is made. Read SEC document |
| February 12, 2020 Filed Feb 19, 2020 18:04 UTC Amendment |
GUT THOMAS10% owner
|
Disposition to issuerCommon Stock | 1,947,584 | $30.00 | $58,427,520.00 |
DisclosureSEC source: 0001104659-20-022929 · tm209304-1_form4a.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,916,456 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. Read SEC document |
| February 12, 2020 Filed Mar 5, 2020 11:32 UTC Amendment |
GUT THOMAS10% owner
|
Disposition to issuerCommon Stock | 1,949,929 | $30.00 | $58,497,870.00 |
DisclosureSEC source: 0001104659-20-029536 · tm2011767d1_form4a.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914,111 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. F2 · shares: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock. F2 · balance_after: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock. Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:29 UTC Amendment |
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
|
Disposition to issuerCommon Stock | 2,103,894 | $30.00 | $63,116,820.00 |
DisclosureSEC source: 0001209191-20-020220 · doc4a.xml · nonDerivative · entry 1 SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,223,166 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 15,874 | $30.00 | $476,220.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 31,864 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 33,252 | $30.00 | $997,560.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Foundation Disclosed balance after: 66,748 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 3,825 | $30.00 | $114,750.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 7,676 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
Disposition to issuerCommon Stock | 1,462,636 | $30.00 | $43,879,080.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935,964 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 17:26 UTC Amendment |
Waldin Jan-PaulDirector
|
Disposition to issuerCommon Stock | 99,757 | $30.00 | $2,992,710.00 |
DisclosureSEC source: 0001209191-20-020219 · doc4a.xml · nonDerivative · entry 1 Waldin Jan-Paul · CIK 0001733176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,243 Read SEC document |
| February 03, 2020 Filed Feb 13, 2020 17:07 UTC |
RENNES FONDATION10% owner
|
GiftCommon Stock | 5,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009318 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,282 Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Exercise / conversionStock Option · Derivative | 46,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · derivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199,500 Underlying: Common Stock · 46,000 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Exercise / conversionStock Option · Derivative | 77,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · derivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245,500 Underlying: Common Stock · 77,000 shares Expires 2020-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Exercise / conversionCommon Stock | 123,000 | $3.75 | $461,250.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,706,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2019 Filed Dec 11, 2019 15:52 UTC |
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option · Derivative | 1,000,000 | $11.12 Strike: $11.12 | $11,120,000.00 |
DisclosureSEC source: 0001209191-19-060015 · doc4.xml · derivative · entry 1 SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625,000 Underlying: Common Stock · 1,000,000 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On December 6, 2019 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options will vest in two equal installments on the six-month anniversary and the first anniversary of the Grant Date. F1 · derivative.exercise_price: On December 6, 2019 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options will vest in two equal installments on the six-month anniversary and the first anniversary of the Grant Date. Read SEC document |
| November 29, 2019 Filed Dec 4, 2019 15:29 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Exercise / conversionStock Option · Derivative | 185,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-19-059014 · doc4.xml · derivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 185,000 shares Expires 2019-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 4, 2019 15:29 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
Exercise / conversionCommon Stock | 185,000 | $3.75 | $693,750.00 |
DisclosureSEC source: 0001209191-19-059014 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 15:05 UTC |
SHIVASWAMY SUSHMAChief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001209191-19-055793 · doc4.xml · derivative · entry 1 SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 15:06 UTC |
HAN QUEENAVP Finance & HR
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001209191-19-055794 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-06 Read SEC document |
| September 06, 2019 Filed Sep 6, 2018 16:35 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
SaleCommon Stock | 7,159 | $3.69 | $26,396.66 |
DisclosureSEC source: 0001209191-18-049834 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880,421 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6 to $3.89, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2019 Filed Sep 9, 2019 17:06 UTC |
Libby PeterDirector
|
GrantDirector Stock option · Derivative | 25,000 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-19-048852 · doc4.xml · derivative · entry 1 Libby Peter · CIK 0001784088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-07-09 Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 17:24 UTC |
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option · Derivative | 300,000 | $7.45 Strike: $7.45 | $2,235,000.00 |
DisclosureSEC source: 0001209191-19-039527 · doc4.xml · derivative · entry 1 SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On June 27, 2019 (the Grant Date) John Simard was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date. F1 · derivative.exercise_price: On June 27, 2019 (the Grant Date) John Simard was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 15:30 UTC |
MacAdam Donald H.Director
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $7.45 | $0.00 |
DisclosureSEC source: 0001209191-19-039641 · doc4.xml · derivative · entry 1 MacAdam Donald H. · CIK 0001735261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-27 Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 15:33 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $7.45 | $0.00 |
DisclosureSEC source: 0001209191-19-039647 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-27 Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 19:36 UTC |
Waldin Jan-PaulDirector
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $7.45 | $0.00 |
DisclosureSEC source: 0001209191-19-039652 · doc4.xml · derivative · entry 1 Waldin Jan-Paul · CIK 0001733176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-27 Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 10:36 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 1,200,000 | $8.25 | $9,900,000.00 |
DisclosureSEC source: 0001209191-19-034978 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,110,282 F1 · kind: Represents a purchase from the underwriter in the Issuer's public offering. Read SEC document |
| March 07, 2019 Filed Mar 4, 2019 16:13 UTC |
SHIVASWAMY SUSHMAChief Scientific Officer
|
Exercise / conversionStock options · Derivative | 4,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-19-015553 · doc4.xml · derivative · entry 3 SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 4,500 shares Expires 2019-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 16:25 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 16,426 | $7.91 | $129,929.66 |
DisclosureSEC source: 0001209191-19-016489 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,910,282 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.04, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 10:29 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 34,999 | $8.13 | $284,541.87 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 3 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,893,856 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $8.25, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · balance_after: Number is revised to include 150,000 shares which were inadvertently omitted from prior filings. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 10:29 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 5,302 | $8.19 | $43,423.38 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858,857 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.31, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2019 Filed Mar 4, 2019 10:29 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 5,273 | $8.13 | $42,869.49 |
DisclosureSEC source: 0001209191-19-015316 · doc4.xml · nonDerivative · entry 1 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853,555 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.23, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2019 Filed Feb 14, 2019 14:38 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 40,000 | $10.00 | $400,000.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 6 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698,282 Read SEC document |
| February 07, 2019 Filed Mar 4, 2019 16:13 UTC |
SHIVASWAMY SUSHMAChief Scientific Officer
|
SaleCommon Stock | 4,500 | $10.00 | $45,000.00 |
DisclosureSEC source: 0001209191-19-015553 · doc4.xml · nonDerivative · entry 2 SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 07, 2019 Filed Mar 4, 2019 16:13 UTC |
SHIVASWAMY SUSHMAChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,500 | $2.50 | $11,250.00 |
DisclosureSEC source: 0001209191-19-015553 · doc4.xml · nonDerivative · entry 1 SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 14, 2019 14:38 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 30,000 | $9.49 | $284,700.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 5 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658,282 Read SEC document |
| February 06, 2019 Filed Feb 14, 2019 14:38 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 35,000 | $8.93 | $312,550.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 4 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,628,282 Read SEC document |
| January 04, 2019 Filed Mar 4, 2019 16:48 UTC |
HAN QUEENAVP Finance & HR
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0001209191-19-015691 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-01-04 Read SEC document |
| January 04, 2019 Filed Mar 4, 2019 16:51 UTC |
SHIVASWAMY SUSHMAChief Scientific Officer
|
GrantStock Option · Derivative | 15,000 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0001209191-19-015702 · doc4.xml · derivative · entry 1 SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-01-04 Read SEC document |
| January 02, 2019 Filed Feb 14, 2019 14:38 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 900 | $5.15 | $4,635.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 3 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593,282 Read SEC document |
| December 27, 2018 Filed Dec 28, 2018 16:17 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 1,364 | $4.92 | $6,705.83 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 32,702 Read SEC document |
| December 27, 2018 Filed Feb 14, 2019 14:38 UTC |
RENNES FONDATION10% owner
|
PurchaseCommon Stock | 2,200 | $4.98 | $10,956.00 |
DisclosureSEC source: 0001209191-19-010053 · doc4.xml · nonDerivative · entry 2 RENNES FONDATION · CIK 0001094515 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,592,382 Read SEC document |
| December 27, 2018 Filed Mar 4, 2019 15:40 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 1,364 | $4.92 | $6,705.83 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 47,738 Read SEC document |
| December 26, 2018 Filed Dec 28, 2018 16:17 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 3,600 | $5.00 | $17,996.04 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 31,338 Read SEC document |
| December 26, 2018 Filed Mar 4, 2019 15:40 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 18,636 | $5.07 | $94,566.52 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 46,374 Read SEC document |
| December 24, 2018 Filed Dec 28, 2018 16:17 UTC |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 24,838 | $5.88 | $146,097.12 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 27,738 Read SEC document |
| December 24, 2018 Filed Mar 4, 2019 15:40 UTC Amendment |
MCKENZIE W THORPEDirector · 10% owner
|
PurchaseCommon Stock | 24,838 | $5.88 | $146,097.12 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 27,738 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.